INS and cancer: Dysfunction of PLCG1 is closely associated with inflammation, immune disorders, and cancer (Koss et al., 2014), and in vitro testing revealed that PLCG1 mediated high glucose levels and insulin-induced cell proliferation and migration in SW480 colon cancer cells (Tomas et al., 2012).